GC31621
ACT 178882
Also known as (3R,4S)-N-[[2-chloro-5-(2-methoxyethyl)phenyl]methyl]-N-cyclopropyl-4-[6-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]-3-pyridinyl]piperidine-3-carboxamide
ACT 178882 is a new Renin inhibitor with an IC50 of 1·4 nM
ChemicalCAS1007392-69-9MW647.03FormulaC33H38Cl3N3O4
- CAS number
- 1007392-69-9
- Molecular weight
- 647.03
- Formula
- C33H38Cl3N3O4
- Solubility
- Soluble in DMSO
- InChIKey
- PGSRKJVMAOWDEC-SXOMAYOGSA-N
- Catalogue number
- GC31621
- Brand
- GLPBIO
Computed properties PubChem CID 12001785 · XLogP 6.5 · TPSA 72.9 Ų · H-bond donors 1
- XLogP
- 6.5
- TPSA
- 72.9 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 13
- Heavy atoms
- 43
SMILES CC1=CC(=C(C(=C1)Cl)OCCOC2=NC=C(C=C2)[C@H]3CCNC[C@@H]3C(=O)N(CC4=C(C=CC(=C4)CCOC)Cl)C5CC5)Cl
Computed descriptors from PubChem (CID 12001785), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il